Before taking Ziihera(Zanidatamab)

This part highlights critical safety warnings and necessary monitoring during treatment.

Important Safety Warnings

Key precautions include the risk of embryo-fetal toxicity, necessitating pregnancy testing and effective contraception. Cardiac function must be assessed via LVEF measurement before and during therapy due to the risk of left ventricular dysfunction. Vigilance for infusion-related reactions is essential, and severe diarrhea requires prompt management. Permanent discontinuation is mandated for severe pneumonitis, life-threatening infusion reactions, or symptomatic heart failure.